- Home
- ALRS vs ORGO Comparison
ALRS vs ORGO Comparison
Compare ALRS & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRS
- ORGO
- Stock Information
- Founded
- ALRS 1879
- ORGO 1985
- Country
- ALRS United States
- ORGO United States
- Employees
- ALRS N/A
- ORGO N/A
- Industry
- ALRS Major Banks
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ALRS Finance
- ORGO Health Care
- Exchange
- ALRS Nasdaq
- ORGO Nasdaq
- Market Cap
- ALRS 572.8M
- ORGO 465.6M
- IPO Year
- ALRS 2019
- ORGO N/A
- Fundamental
- Price
- ALRS $21.72
- ORGO $5.03
- Analyst Decision
- ALRS Hold
- ORGO Buy
- Analyst Count
- ALRS 5
- ORGO 2
- Target Price
- ALRS $23.20
- ORGO $6.50
- AVG Volume (30 Days)
- ALRS 69.6K
- ORGO 1.0M
- Earning Date
- ALRS 07-28-2025
- ORGO 08-07-2025
- Dividend Yield
- ALRS 3.87%
- ORGO N/A
- EPS Growth
- ALRS 118.02
- ORGO N/A
- EPS
- ALRS 1.08
- ORGO N/A
- Revenue
- ALRS $224,218,000.00
- ORGO $458,760,000.00
- Revenue This Year
- ALRS $40.80
- ORGO $1.10
- Revenue Next Year
- ALRS $3.69
- ORGO $9.93
- P/E Ratio
- ALRS $20.04
- ORGO N/A
- Revenue Growth
- ALRS 35.73
- ORGO 5.35
- 52 Week Low
- ALRS $15.78
- ORGO $2.28
- 52 Week High
- ALRS $24.41
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ALRS 46.65
- ORGO 66.76
- Support Level
- ALRS $21.63
- ORGO $4.30
- Resistance Level
- ALRS $22.27
- ORGO $5.02
- Average True Range (ATR)
- ALRS 0.47
- ORGO 0.28
- MACD
- ALRS -0.12
- ORGO 0.05
- Stochastic Oscillator
- ALRS 23.87
- ORGO 99.60
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.